ArkeaBio is a global agricultural bioscience company developing a safe, cost-effective vaccine to reduce methane emissions from cattle all over the world. We are the first to successfully demonstrate a proof-of-concept vaccine. It’s the safest, most cost-effective solution for reducing greenhouse gas emissions in agriculture, and it’s the only one that can be quickly and sustainably scaled to reach all the world’s cattle. It’s a singular, scalable solution that delivers value to farmers, brands, consumers and our climate.
Company Details
- Employees
- 36
- Founded
- 2021
- Address
- 500 Rutherford Ave, Charlestown,massachusetts 02129,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.arkeabio.com
- HQ
- Charlestown, Massachusetts
Arkeabio™ Questions
Arkeabio™'s website is http://www.arkeabio.com
Arkeabio™'s LinkedIn profile is https://www.linkedin.com/company/arkeabio
Arkeabio™ has
36 employees.
View email and phone details for 36
employees at Arkeabio™.
Arkeabio™'s industry is
Biotechnology Research
Arkeabio™'s top competitors are
Zymergen,
Ginkgo Bioworks, Inc.,
Evozyne,
Galy,
Enevolv,
Everse.ai,
Inari,
Invaio,
Hoofprint Biome,
Robigo.
Arkeabio™'s categories are Biotechnology Research
Arkeabio™'s founding year is 2021
